Antiseizure Medication Use and Outcomes After Suspected or Confirmed Acute Symptomatic Seizures
This study suggests that etiology and electrographic findings are associated with ASM treatment for acute symptomatic seizures and EAs; ASM treatment was not associated with functional outcomes. Comparative effectiveness studies are indicated to identify which patients may benefit from ASMs and to determine the optimal treatment duration.
Authors
- Sakhi Bhansali
- Natalie Erlich‐Malona (ORCID: https://orcid.org/0000-0002-8524-4914)
- Monica B. Dhakar (ORCID: https://orcid.org/0000-0001-9275-2784)
- Phillip Oluwatobi Awodutire (ORCID: https://orcid.org/0000-0001-8750-3548)
- Pradeep Chandan (ORCID: https://orcid.org/0000-0001-8550-1266)
- Zachary McKee
- Hunter Rice (ORCID: https://orcid.org/0009-0001-9249-3636)
- Fernando H. Ibanhes
- Neishay Ayub (ORCID: https://orcid.org/0000-0001-5490-8776)
- MarieElena Byrnes (ORCID: https://orcid.org/0000-0002-2646-2735)
- Sahar F. Zafar (ORCID: https://orcid.org/0000-0001-5252-5376)
- Muhammad Adnan Haider (ORCID: https://orcid.org/0000-0002-4888-7646)
- Adithya Sivaraju (ORCID: https://orcid.org/0000-0002-6027-9205)
- Clio Rubiños (ORCID: https://orcid.org/0000-0002-1680-2302)
- Vineet Punia (ORCID: https://orcid.org/0000-0002-0552-6736)
- Arthor Smith-Ayala
- Elizabeth Tveter
- Skylar Lewis
- Alexis DeMarco
Institutions
- University of North Carolina at Chapel Hill (US)
- Cleveland Clinic (US)
- Brown University (US)
- Yale University (US)
- University of California San Diego (US)
- Massachusetts General Hospital (US)
- Xenon Pharmaceuticals (Canada) (CA)
Publication Details
- Journal
- JAMA Neurology
- Published
- 2024-09-23
- DOI
- https://doi.org/10.1001/jamaneurol.2024.3189
- Citations
- 13
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.01